Latest Schedule 13G passive stakes

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.8% of Western Alliance Bancorp's common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, disclosing a beneficial ownership of 5.9% in Ambarella Inc. common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has updated its beneficial ownership filing for CF Industries Holdings Inc., now holding 5.5% of the common stock.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5,372,456 shares, representing 4.5% of Booz Allen Hamilton Holdings' common stock.

T. Rowe Price Associates, Inc. has updated its beneficial ownership filing for Kodiak Sciences Inc., reporting a 5.2% stake as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.6% of Sensata Technologies Holding's common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 5.6% of Keysight Technologies' common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Wingstop Inc. common stock.

T. Rowe Price Associates, Inc. has updated its Schedule 13G filing to reflect beneficial ownership of 5.6% of Rocket Companies, Inc. Class A common stock as of June 30, 2026.

Baron Capital Group, along with its affiliates, has reported an amendment to its Schedule 13G filing, indicating a change in its beneficial ownership of CareDx, Inc. common stock.

AQR Capital Management, through its affiliates, has reported beneficial ownership of 5.13% of Roman DBDR Acquisition Corp. II's Class A ordinary shares as of June 30, 2026.

AQR Capital Management, through its subsidiaries, has reported beneficial ownership of 4.63% of Paloma Acquisition Corp I's Class A ordinary shares as of June 30, 2026.

A group of Ameriprise Financial entities has disclosed a combined beneficial ownership of 17.7% of Empire State Realty Trust's Class A Common Stock.

A group of Ameriprise Financial entities has disclosed a combined beneficial ownership of 17.7% of Empire State Realty Trust's Class A Common Stock.

AQR Capital Management entities report a beneficial ownership of 7.02% in Spark I Acquisition Corp's Class A ordinary shares as of June 30, 2026.

Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 167,513 ordinary shares, representing 4.99% of Wearable Devices Ltd.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 3,436,000 shares, representing 5.58% of Voyager Therapeutics, Inc.'s common stock, as of June 30, 2026.

Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting beneficial ownership of 4.99% of Vivos Therapeutics, Inc. common stock as of June 30, 2026.

Howard Lee and associated entities have filed an exit statement for Lucas GC Ltd, reporting beneficial ownership below the 5% threshold.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 7,024,000 shares, representing 7.76% of Verastem, Inc.'s common stock, as of June 30, 2026.

Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 4,079,129 shares, representing 7.33% of VSee Health, Inc.'s common stock.

Ameriprise Financial and Columbia Management report a combined 10.6% beneficial ownership of Hamilton Beach Brands Holding Company's Class A Common Stock as of June 30, 2026.

Ameriprise Financial and Columbia Management report a combined 10.6% beneficial ownership of Hamilton Beach Brands Holding Company's Class A Common Stock as of June 30, 2026.

Armistice Capital, LLC and Steven Boyd have jointly reported beneficial ownership of 1,572,539 shares, representing 1.67% of the outstanding common stock of Travere Therapeutics, Inc.

Armistice Capital, LLC and Steven Boyd report acquiring a 9.91% beneficial ownership stake in Trevena, Inc., holding 95,000 shares.

Armistice Capital, LLC, along with Steven Boyd, has reported beneficial ownership of 54,554 shares, representing 9.99% of the common stock of Tenon Medical, Inc.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 6,364,000 shares, representing 9.79% of the common stock of Treace Medical Concepts, Inc.

Armistice Capital, LLC and Steven Boyd have jointly reported a beneficial ownership of 9.99% in Stryve Foods, Inc. Class A Common Stock.

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 9.38% of Sangamo Therapeutics, Inc.'s common stock, filing as a Schedule 13G.

Armistice Capital, LLC and Steven Boyd have jointly reported beneficial ownership of 3,328,000 shares, representing 7.29% of Rapid Micro Biosystems, Inc.'s Class A common stock.